Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

425 ARTÍCULOS , VIENDO DEL 391 AL 405

Prevalence and risk factors for depressive symptoms in older adults with preclinical Alzheimer's disease: A systematic review and meta-analysis

Chen D, Zhu Z, Shi Y, Li H, Lin R.

Int J Nurs Stud. 2026 Jan;173:105259. doi: 10.1016/j.ijnurstu.2025.105259. Epub 2025 Oct 22.

A Scoping Review of Clinical Utility from the Montreal Cognitive Assessment Memory Index Score

Kronenberger OR, Kaser AN, Schaffert J, Thakkar VJ, Goette W, LoBue C, Lacritz LH.

J Geriatr Psychiatry Neurol. 2026 May;39(3):261-276. doi: 10.1177/08919887251366698. Epub 2025 Aug 18.

Intranasal insulin for mild cognitive impairment and Alzheimer's disease: A systematic review and meta-analysis of randomized controlled trials

Silva AMP, Gonçalves OR, Tudella GCN, Nascimento MVS, Pereira MAOM, Nantes LAO, Fernandes JVA, Quiroga DG, Lima DVS Jr, Franco ES, Maia MBS.

Rev Neurol (Paris). 2026 Jan-Feb;182(1-2):36-48. doi: 10.1016/j.neurol.2025.11.005. Epub 2025 Dec 22.

Lost in Space and Thought: Navigating the Cognitive Map in Alzheimer's Disease

Zhao B, Zhou S, Wei T, Xu J, Geng C, Wang Z, Tang Y.

Neurosci Bull. 2026 Mar;42(3):697-711. doi: 10.1007/s12264-025-01541-x. Epub 2025 Nov 7.

Globus Pallidus Iron Relates to Cognitive Impairment in Alzheimer's Disease: Evidence From MRI-Based Meta-Analysis

Mieling M, Wiskow C, Bunzeck N.

Ann N Y Acad Sci. 2026 Feb;1556(1):e70078. doi: 10.1111/nyas.70078. Epub 2025 Dec 4.

Comparative efficacy and safety of different brexpiprazole doses for agitation in Alzheimer's disease: A systematic review and network meta-analysis

Kandeel M, Mahmoud M.

J Alzheimers Dis. 2026 Feb;109(3):1089-1098. doi: 10.1177/13872877251404500. Epub 2025 Dec 8.

Speech pause and speech rate for evaluating Alzheimer's and mild cognitive impairment: A meta-analysis

Cohen AS, Divers R, Calamia M, Masucci M, Granrud OE, Corporandy A, Warren KK, Elvevåg B, Chandler C, Diaz-Asper C.

J Int Neuropsychol Soc. 2026 Jan;32(1):24-31. doi: 10.1017/S1355617725101677. Epub 2025 Dec 11.

Task-based fMRI brain activation in mild cognitive impairment and Alzheimer's disease: an ALE meta-analysis

Lee ZL, Li JJ, Siew SKH, Billaud CHA, Yu J.

Geroscience. 2026 Apr;48(2):3069-3096. doi: 10.1007/s11357-025-01850-z. Epub 2025 Aug 29.

Reconciling recommendations for ethical sharing of biomarker results with Alzheimer's disease research participants: A systematic review and qualitative synthesis

Webster H, Zelinsky M, Rico V, Martinez K, Sankary L.

J Alzheimers Dis. 2026 Mar;110(1):46-57. doi: 10.1177/13872877251392555. Epub 2025 Nov 5.

Association of neighborhood disadvantage with Alzheimer's disease pathology and the stability of blood-based biomarker performance

Myoraku A, Hausle I, Mila-Aloma M, Thropp P, Wang LA, Doraiswamy PM, Tosun D; Alzheimer’s Disease Neuroimaging Initiative*.

J Prev Alzheimers Dis. 2026 Feb;13(2):100445. doi: 10.1016/j.tjpad.2025.100445. Epub 2025 Nov 23.

Amyloid Clearance and Transient CSF Aβ40 Reduction in a Case of ARIA-E/H Following Lecanemab Treatment

Naeshiro Y, Kitani-Morii F, Kasai T, Tanaka E, Kobayashi F, Ohara T.

Intern Med. 2026 Apr 1;65(7):1056-1060. doi: 10.2169/internalmedicine.6070-25. Epub 2025 Aug 21.

Clinimetrics: Towards a diagnostic neuropsychology grounded in Alzheimer's disease

Ilardi CR.

J Neuropsychol. 2026 Mar;20(1):246-255. doi: 10.1111/jnp.70008. Epub 2025 Aug 13.

Hippocampal Atrophy on Magnetic Resonance Imaging as a Surrogate Marker for Clinical Benefit and Neurodegeneration in Early Symptomatic Alzheimer's Disease: Synthesis of Evidence from Observational and Interventional Trials

Abushakra S, Doraiswamy PM, Hey JA, Tosun D, Barkhof F, Barakos J, Petrella J, Kesslak JP, Power A, Sabbagh M, Porsteinsson A, Cohen S, Gauthier S, Ritchie C, Watson D, McSweeney E, Boada M, Liang E, Bracoud L, McLaine R, Flint S, Schaefer JF, Yu J, Bray M, Hendrix S, Dickson S, Durrant A, Albayrak A, Tolar M.

CNS Drugs. 2026 Feb;40(2):199-214. doi: 10.1007/s40263-025-01251-y. Epub 2025 Dec 1.

Alzheimer's disease diagnosis and treatment: From pathophysiological insights to therapeutic advances in the era of precision neurology (2025 review)

Kim M, Kwon H, Sohn S, Lee WJ, Cho K, Kim GW.

J Alzheimers Dis. 2026 Jan;109(1):17-33. doi: 10.1177/13872877251391820. Epub 2025 Oct 29.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias